BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui S, Li C. RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA. Oncol Rep 2021;45:111. [PMID: 33907841 DOI: 10.3892/or.2021.8062] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Cui S. METTL3 ‐mediated m6A modification of lnc RNA RHPN1‐AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K / AKT pathway. Clinical Laboratory Analysis 2022. [DOI: 10.1002/jcla.24761] [Reference Citation Analysis]
2 Shao T, Jiang X, Bao G, Li C, Guo C, Hashmi AA. Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/7571066] [Reference Citation Analysis]